NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000047964

Registered date:01/07/2022

Study for overcoming the severe infertility by new indole compound (MA-5)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedinfertility patients
Date of first enrollment2022/07/01
Target sample size80
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeUsing discarded sperm, effect of MA-5 exposure is evaluated for sperm function (kinetics and fertilization ability) and mitochondrial function (ART production), and it is compared with non-treated counterpart.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum42years-old
GenderMale
Include criteria
Exclude criteriaPatient who has infection, such as hepatitis B virus, hepatitis C virus, Syphilis and HIV. Patient who has been registered to other clinical study. Patient who are using supplement drugs which affects mitochondrial function, such as Vit C&E, CoQ10 etc. Sample may not be used if the sperm parameter is not enough to analyze, even if patient eligible to enter this study and agreed.

Related Information

Contact

public contact
Name Masahito Tachibana
Address 1-1 Seiryomachi, Aoba-ward, Sendai, Miyagi, 980-8574 Japan Japan 9808574
Telephone 0227177254
E-mail masahito.tachibana.c1@tohoku.ac.jp
Affiliation Tohoku university hospital Dept of OB/GYN
scientific contact
Name Masahito Tachibana
Address 1-1 Seiryomachi, Aoba-ward, Sendai, Miyagi, 980-8574 Japan Japan
Telephone 0227177254
E-mail masahito.tachibana.c1@tohoku.ac.jp
Affiliation Tohoku university graduate school of medicine Department of perinatology